Jiangxi Launches Its First Traditional Chinese Medicine Industry Fund to Drive High-Quality Sector Growth

Jiangxi Takes Another Solid Step Toward High-Quality Development of Its Traditional Chinese Medicine Industry. On September 11, the signing ceremony for the Ganjiang Traditional Chinese Medicine (TCM) Industry Integration Fund was held in Jiangxi Province. Xiao Yuwen, Deputy Secretary of the Party Working Committee and Director of the Administrative Committee of Ganjiang New Area; Liao Jieyuan, Chairman of WeDoctor Group; and Gong Hongjia, Chairman of Jiadao Capital, jointly signed the agreement to establish the “Ganjiang TCM Industry Integration Fund” (hereinafter referred to as the “Integration Fund”). As the first TCM industry fund in Jiangxi Province, the Integration Fund has an initial capital size of RMB 2 billion. Co-established by the government, industrial platforms, and technology investors, the fund will promote the high-quality development of Jiangxi’s TCM sector and industry through a model that leverages investment to drive business attraction and resource integration.

In recent years, Jiangxi Province has seized the opportunity presented by the establishment of the National Comprehensive Reform Demonstration Zone for Traditional Chinese Medicine (TCM) to embark on its journey toward becoming a leading province in TCM. The successful convening of the Shanghai Cooperation Organization Forum on Traditional Medicine in Nanchang has also provided significant opportunities for Jiangxi to promote the global reach of TCM and integrate it into the dual circulation development paradigm, encompassing both domestic and international markets. As the first approved fund under the market-oriented operations of Jiangxi State-owned Capital Holding Group, the Industrial Integration Fund has received strong support from state-owned assets.

As the head of operations and management for an industrial consolidation fund, renowned tech investor Gong Hongjia has successfully invested in companies such as Hikvision, creating a miracle of investment returns in the history of Chinese venture capital. Jiadao Capital has long been committed to empowering the traditional Chinese medicine (TCM) industry with technology, continuously laying out its industrial strategy to improve the cultivation standards of TCM medicinal herbs and the quality of TCM materials, with cumulative investments exceeding RMB 10 billion. Gong Hongjia stated that the consolidation fund will further leverage Jiangxi’s endowments in TCM resources, collaborate with various industry stakeholders to build an innovation incubation and cultivation system covering the entire industry chain, and attract more high-quality projects and enterprises to settle in the region.

As an industry platform, WeDoctor is the world’s leading digital health platform, dedicated to empowering all stakeholders across the healthcare value chain, including healthcare providers, payers, and supply chain participants. Liao Jieyuan stated that WeDoctor has established three core business segments: the Digital Health Community, the Pharmaceutical and Medical Device Trading Platform, and the Bianque Traditional Chinese Medicine (TCM) division. With the launch of its industry integration fund, WeDoctor will fully leverage the capabilities of these three segments to build a digital TCM industrial cluster, foster coordinated development across the primary, secondary, and tertiary sectors, and create a closed-loop service system from production sites to patients.

“The establishment of the fund comes at an opportune time,” said Xiao Yuwen. By leveraging WeDoctor’s informational advantages and professional operational capabilities in the pharmaceutical and healthcare sectors, and integrating Jiadao Capital’s comprehensive industry chain layout, extensive industrial investment experience, and project investment channels in the pharmaceutical industry, the initiative will consolidate Jiangxi’s traditional Chinese medicine (TCM) industry resources. This synergy is poised to drive exponential growth and pioneering breakthroughs in the TCM industry within the Ganjiang New Area.